297 Editorial

Original Papers

300 The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). W. H. VAN BRAKEL, A. M. ANDERSON, S. G. WITHINGTON, R. P. CROFT, P. G. NICHOLLS, J. H. RICHARDUS AND W. C. S. SMITH

311 Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3). J. H. RICHARDUS, S. G. WITHINGTON, A. M. ANDERSON, R. P. CROFT, P. G. NICHOLLS, W. H. VAN BRAKEL AND W. C. S. SMITH

319 Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the tripods trials. J. H. RICHARDUS, S. G. WITHINGTON, A. M. ANDERSON, R. P. CROFT, P. G. NICHOLLS, W. H. VAN BRAKEL AND W. C. S. SMITH

328 Treatment duration of reversal reaction: a re-appraisal. Back to the past. B. NAAFS

337 Impairments and Hansen’s disease control in Rondonia State, Amazon Region of Brazil. C. R. DE OLIVEIRA, M. DE J. F. DE ALENCAR, S. A. DE S. NETO, L. F. LEHMAN AND P. A. M. SCHREUDER

349 Delay in presentation, an indicator for nerve function status at registration and for treatment it outcome -- the experience of the Bangladesh Acute Nerve Damage Study cohort. P. G. NICHOLLS, R. P. CROFT, J. H. RICHARDUS, S. G. WITHINGTON AND W. C. S. SMITH

357 Unexplained delayed nerve impairment in leprosy after treatment. N. R. ROSENBERG, W. R. FABER AND M. VERMEULEN

366 WHO disability grading: operational definitions. J. W. BRANDSMA AND W. H. VAN BRAKEL

374 Ulnar and median nerves in paucibacillary leprosy -- a follow-up study of electrophysiological -2 functions in patients before and after nerve trunk decompression. S. HUSAIN, A. KUMAR, V. S. YADAV AND G. N. MALAVIYA

Case Report

383 Bilateral facial palsy in Hansen’s disease. A. C. INAMADAR AND A. PALIT

Letters to the Editor

386 Chronic recurrent ENL, steroid dependent: long-term treatment with high-dose clofazimine. P. A. M. SCHREUDER AND B. NAAFS

Author Index 2003

Subject Index 2003